logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2018 – Using cabazitaxel before androgen receptor therapy may maximise clinical benefit in poor prognosis mCRPC

Trial reports effect of treatment sequence and prognostic value of circulating tumour DNA